Skip to content
Assyro AI
Purple Book reference family · 351(a) biologic

Albumin (Human) (Albuked, Plasbumin-20, Plasbumin-25, Plasbumin-5)

Albumin (Human) is an FDA-licensed reference biologic from Grifols Therapeutics LLC.

351(a) biologicBLA 101138 Grifols Therapeutics LLC
Biosimilars
0
Interchangeables
0
Listed patents
0
Reference approved
1942

Reference product

Originator biologic
351(a)BLA 101138

Albuked, Plasbumin-20, Plasbumin-25, Plasbumin-5 Albumin (Human)

Grifols Therapeutics LLC

View full reference-product record
Approved
Marketing
Rx
Center
CBER
Patents
None listed

Molecular structure

RCSB Protein Data Bank

Experimental 3D structure for Albumin (Human) from the RCSB Protein Data Bank (PDB 1AO6).

3D molecular structure of Albumin (Human) (PDB entry 1AO6)

Interactive biological assembly from PDB entry 1AO6. Drag to rotate, scroll to zoom, and inspect the full atomic structure right here, with no need to leave the page.

Exclusivity & patent cliffs

Protection horizon
  1. Reference approval

    Approval date of the reference Albumin (Human) product.

    85 yr 2 mo ago

Albumin (Human): frequently asked questions

Reference exclusivity, biosimilars, interchangeability, and patents for this molecule, from the FDA Purple Book.

Built from official FDA Purple Book records (monthly downloads, the Advanced Search interface, and the published Patent List), with reference-product, license-type, and exclusivity context for Albumin (Human).

Related FDA reference tools

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.